eHealth
Analysing and guiding mHealth solutions
Welcome to our team!
We are honoured to be joined by Louise Vandevelde as Medical Affairs manager.
Devices vs. pharmaceuticals
Comparing clinical & economical value of a device vs. a pharmaceutical
Welcome to our team!
We are honoured to be joined by Kurt Ceuppens as Director Regulatory Affairs & Portfolio.
CAR-T
Supporting the CAR-T reimbursement framework
Devices strategic shift
Health economic assessment & value messaging comparing device types for strategic shift
Diabetes care
Mapping the diabetes care ecosystem
Patients affected by diabetes, their doctors, and pharmacists still face hurdles in their journey. Optimising diabetes care is amongst the goals in Medical Affairs.
Experience in respiratory medicine
Specific pulmonology experience
Chronic obstructive pulmonary disease (COPD), still holds unmet needs, such as exacerbation, symptom control, and underdiagnose.
Market Access requires a holistic approach
Obtaining a price and reimbursement is often quite a challenge for innovative medicines. This requires a holistic approach by a cross-functional team and an open dialogue with all relevant stakeholders.
More explanation by Sven Tops and Frank Vanderdonck, Managing Partners at AxTalis